D3Penta 21 clinical trial design A randomised noninferiority trial with nested drug licensing substudy to assess dolutegravir and lamivudine fixed dose formulations for the maintenance of virological suppression in children with HIV1 infection aged 2

Simple item page
dc.article.end-page12en
dc.article.start-page1en
dc.citation.doi10.1016/J.CCT.2024.107540en
dc.contributor.authorA Turkovaen
dc.contributor.authorM Chanen
dc.contributor.authorC Kityoen
dc.contributor.authorA Kekitiinwaen
dc.contributor.authorE et alen
dc.contributor.authorAvyi Violarien
dc.contributor.authorEbrahim Variavaen
dc.date.accessioned2025-04-06T16:50:48Z
dc.facultyFACULTY OF HEALTH SCIENCESen
dc.identifier.citationWOSen
dc.identifier.issn1551-7144en
dc.identifier.urihttps://hdl.handle.net/10539/44594
dc.journal.titleD3Penta 21 clinical trial design A randomised noninferiority trial with nested drug licensing substudy to assess dolutegravir and lamivudine fixed dose formulations for the maintenance of virological suppression in children with HIV1 infection aged 2en
dc.journal.volume142en
dc.publisherELSEVIER SCIENCE INCen
dc.titleD3Penta 21 clinical trial design A randomised noninferiority trial with nested drug licensing substudy to assess dolutegravir and lamivudine fixed dose formulations for the maintenance of virological suppression in children with HIV1 infection aged 2en
dc.typeJournal Articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Journal Article.pdf
Size:
644.08 KB
Format:
Adobe Portable Document Format
Description:
Bitstream uploaded by REST Client
Download

Collections

Academic Wits Research Outputs (All submissions)